Please assess the completion status of the following clinical trial:

Trial Title: INTRACEPT: Prospective, Randomized, Multi-center Study Intraosseous Basivertebral Nerve Ablation for Treatment of CLBP

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Skeletally mature subjects at least 25 years of age~* Chronic lower back pain for at least 6 months~* Failure to respond to at least 6 months of non-operative conservative management~Exclusion Criteria:~* Radicular pain~* Current or history of spinal infection~* Modic changes at vertebral bodies other than L3 to S1~* Contraindication to MRI~* Pregnant, lactating or plan to become pregnant in next year~* Has life expectancy of less than 2 years~* Compensated injuries or ongoing litigation regarding back pain/injury, or financial incentive to remain impaired

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- BVN Ablation (Type: ACTIVE_COMPARATOR): BVN ablation with continued standard care
- Standard Care Control (Type: ACTIVE_COMPARATOR): Continue with non-surgical standard care

Based on this trial design, predict the completion outcome and termination type (if applicable).